80 related articles for article (PubMed ID: 2442826)
1. The influence of anticoagulant treatment on the probability of function in femoropopliteal vein bypass surgery: analysis of a clinical series (1970 to 1985) and interim evaluation of a controlled clinical trial.
Kretschmer G; Wenzl E; Piza F; Polterauer P; Ehringer H; Minar E; Schemper M
Surgery; 1987 Sep; 102(3):453-9. PubMed ID: 2442826
[TBL] [Abstract][Full Text] [Related]
2. [Autologous venous bypass in the therapy of arterial occlusive disease of the femoropopliteal area: long-term results].
Kretschmer G; Huk I; Polterauer P; Piza F; Wagner O; Wenzl E; Schemper M
Wien Klin Wochenschr; 1986 Dec; 98(24):830-8. PubMed ID: 3825155
[TBL] [Abstract][Full Text] [Related]
3. [Role of postoperative anticoagulant treatment following femoro-popliteal venous bypass. Interim evaluation of a controlled clinical study].
Kretschmer G; Wenzl E; Huk I; Polterauer P; Ehringer H; Minar E; Schemper M
Wien Klin Wochenschr; 1987 Sep; 99(17):591-5. PubMed ID: 2445114
[TBL] [Abstract][Full Text] [Related]
4. Influence of postoperative anticoagulant treatment on patient survival after femoropopliteal vein bypass surgery.
Kretschmer G; Wenzl E; Schemper M; Polterauer P; Ehringer H; Marçosi L; Minar E
Lancet; 1988 Apr; 1(8589):797-9. PubMed ID: 2895319
[TBL] [Abstract][Full Text] [Related]
5. [Factors determining late patency of aortobifemoral bypass graft].
Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanov PL; Velimirović DB; Marković MM; Pejkić SA; Vukotić AM
Srp Arh Celok Lek; 1997; 125(1-2):24-35. PubMed ID: 17974352
[TBL] [Abstract][Full Text] [Related]
6. Femoropopliteal bypass: in situ or reversed vein grafts? Ten-year results of a randomized prospective study.
Watelet J; Soury P; Menard JF; Plissonnier D; Peillon C; Lestrat JP; Testart J
Ann Vasc Surg; 1997 Sep; 11(5):510-9. PubMed ID: 9302064
[TBL] [Abstract][Full Text] [Related]
7. Vein bypass surgery for femoro-popliteal arteriosclerosis: influence of different risk factors on patient survival and the importance of anticoagulant treatment.
Kretschmer G; Wenzl E; Schemper M; Huk I; Konecny U; Marosi L; Minar E
Eur J Vasc Surg; 1988 Apr; 2(2):77-81. PubMed ID: 3169276
[TBL] [Abstract][Full Text] [Related]
8. Influence of anticoagulant treatment in preventing graft occlusion following saphenous vein bypass for femoropopliteal occlusive disease.
Kretschmer G; Wenzl E; Wagner O; Polterauer P; Ehringer H; Minar E; Schemper M
Br J Surg; 1986 Sep; 73(9):689-92. PubMed ID: 3530366
[TBL] [Abstract][Full Text] [Related]
9. A meta-analysis to compare Dacron versus polytetrafluroethylene grafts for above-knee femoropopliteal artery bypass.
Rychlik IJ; Davey P; Murphy J; O'Donnell ME
J Vasc Surg; 2014 Aug; 60(2):506-15. PubMed ID: 24973288
[TBL] [Abstract][Full Text] [Related]
10. A prospective randomized trial comparing vein with polytetrafluoroethylene in above-knee femoropopliteal bypass grafting.
Burger DH; Kappetein AP; Van Bockel JH; Breslau PJ
J Vasc Surg; 2000 Aug; 32(2):278-83. PubMed ID: 10917987
[TBL] [Abstract][Full Text] [Related]
11. The effect of postoperative smoking on femoropopliteal bypass grafts.
Ameli FM; Stein M; Provan JL; Prosser R
Ann Vasc Surg; 1989 Jan; 3(1):20-5. PubMed ID: 2713228
[TBL] [Abstract][Full Text] [Related]
12. Above-knee polytetrafluoroethylene femoropopliteal bypass graft: Is it a reasonable alternative to the below-knee reversed autogenous vein graft?
O'Donnell TF; Farber SP; Richmand DM; Deterling RA; Callow AD
Surgery; 1983 Jul; 94(1):26-31. PubMed ID: 6857508
[TBL] [Abstract][Full Text] [Related]
13. Influence of hormone replacement therapy on graft patency after femoropopliteal bypass grafting.
Timaran CH; Stevens SL; Grandas OH; Piercy KT; Freeman MB; Goldman MH
J Vasc Surg; 2000 Sep; 32(3):506-16; 516-8. PubMed ID: 10957657
[TBL] [Abstract][Full Text] [Related]
14. Comparing vein with collagen impregnated woven polyester prosthesis in above-knee femoropopliteal bypass grafting.
Tofigh AM; Warnier De Wailly G; Rhissassi B
Int J Surg; 2007 Apr; 5(2):109-13. PubMed ID: 17448975
[TBL] [Abstract][Full Text] [Related]
15. PTFE bypass to below-knee arteries: distal vein collar or not? A prospective randomised multicentre study.
SCAMICOS
Eur J Vasc Endovasc Surg; 2010 Jun; 39(6):747-54. PubMed ID: 20236841
[TBL] [Abstract][Full Text] [Related]
16. Midterm results of autologous saphenous vein and ePTFE pre-cuffed bypass surgery in peripheral arterial occlusive disease.
Donker JM; Ho GH; Te Slaa A; de Groot HG; van der Waal JC; Veen EJ; van der Laan L
Vasc Endovascular Surg; 2011 Oct; 45(7):598-603. PubMed ID: 21757494
[TBL] [Abstract][Full Text] [Related]
17. [Long-term outcomes of femoropopliteal bypass above the knee-joint fissure by means of vascular prosthesis <> in patients with atherosclerotic lesions of lower limb arteries].
Pokrovskiĭ AV; Dan VN; Zotikov AE; Chupin AV; Shubin AA; Tedeev AK
Angiol Sosud Khir; 2007; 13(2):143-9. PubMed ID: 18004274
[TBL] [Abstract][Full Text] [Related]
18. [Long-term patency of reversed and in situ femoro-popliteal bypasses].
Marković DM; Davidović LB; Lotina SI; Kostić DM; Cinara IS; Svetković SD; Marković M; Zivanović N
Srp Arh Celok Lek; 1999; 127(11-12):365-70. PubMed ID: 10686817
[TBL] [Abstract][Full Text] [Related]
19. Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass.
Lumsden AB; Morrissey NJ;
J Vasc Surg; 2015 Mar; 61(3):703-12.e1. PubMed ID: 25720929
[TBL] [Abstract][Full Text] [Related]
20. Prospective randomized study on reversed saphenous vein infrapopliteal bypass to treat limb-threatening ischemia: common femoral artery versus superficial femoral or popliteal and tibial arteries as inflow.
Ballotta E; Renon L; De Rossi A; Barbon B; Terranova O; Da Giau G
J Vasc Surg; 2004 Oct; 40(4):732-40. PubMed ID: 15472602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
